175 related articles for article (PubMed ID: 31765835)
1. Two for the price of one: Prevalence, demographics and treatment implications of multiple HPV mediated Head and Neck Cancers.
Strober W; Shishido S; Wood B; Lewis JS; Kuhs K; Ferris RL; Faden DL
Oral Oncol; 2020 Jan; 100():104475. PubMed ID: 31765835
[TBL] [Abstract][Full Text] [Related]
2. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review of Second Primary Oropharyngeal Cancers in Patients With p16+ Oropharyngeal Cancer.
Bollig CA; Lee DS; Mazul AL; Stepan K; Puram SV; Massa ST; Zenga J; Faden DL; Doering MM; Jackson RS; Pipkorn P
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):733-740. PubMed ID: 32928026
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Human Papilloma Virus Sub Genotypes following Head and Neck Squamous Cell Carcinomas in Asian Continent, A Systematic Review Article.
Bukhari N; Joseph JP; Hussain SS; Khan MA; Wakim MJY; Yahya EB; Arif A; Saleem A; Sharif N
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3269-3277. PubMed ID: 31759348
[TBL] [Abstract][Full Text] [Related]
5. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
6. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and clinicopathological correlation of human papillomavirus in head and neck squamous cell carcinoma in India: A systematic review article.
Nandi S; Mandal A; Chhebbi M
Cancer Treat Res Commun; 2021; 26():100301. PubMed ID: 33401132
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of HPV status among patients with hypopharyngeal carcinoma: a population-based study.
Abdel-Rahman O
Clin Transl Oncol; 2020 Sep; 22(9):1645-1650. PubMed ID: 31939101
[TBL] [Abstract][Full Text] [Related]
9. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
[TBL] [Abstract][Full Text] [Related]
11. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
Morris LG; Sikora AG; Patel SG; Hayes RB; Ganly I
J Clin Oncol; 2011 Feb; 29(6):739-46. PubMed ID: 21189382
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.
Mourad M; Jetmore T; Jategaonkar AA; Moubayed S; Moshier E; Urken ML
J Oral Maxillofac Surg; 2017 Dec; 75(12):2562-2572. PubMed ID: 28618252
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
15. Identifying patterns of failure and secondary primary malignancies in HPV-related oropharyngeal squamous cell carcinomas.
Holstead R; Rasul R; Golden A; Kamdar D; Ghaly M; Teckie S; Frank D; Fantasia J; Seetharamu N
Future Oncol; 2020 Feb; 16(6):199-207. PubMed ID: 31967480
[No Abstract] [Full Text] [Related]
16. Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.
Wang XI; Thomas J; Zhang S
Ann Diagn Pathol; 2012 Jan; 16(1):7-12. PubMed ID: 22001331
[TBL] [Abstract][Full Text] [Related]
17. The evolving landscape of HPV-related neoplasia in the head and neck.
Devins KM; Tetzlaff MT; Baloch Z; LiVolsi VA
Hum Pathol; 2019 Dec; 94():29-39. PubMed ID: 31654690
[TBL] [Abstract][Full Text] [Related]
18. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
D'Souza G; McNeel TS; Fakhry C
Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
20. Incidence of contralateral-bilateral nodes in the human papillomavirus era.
Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO
Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
